NIP
TYRA icon

Nicholas Investment Partners’s Tyra Biosciences TYRA Stock Holding History

Nicholas Investment Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-152,968
Closed -$2.51M – 237
2024
Q1 		$2.51M Buy
+152,968
New +$2.51M 0.26% 137

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Nicholas Investment Partners's TYRA Position: Q2 2024 in Review

Nicholas Investment Partners sold out of Tyra Biosciences (TYRA) in Q2 2024, closing a stake of 152,968 shares — an estimated $2.51M sold.

Nicholas Investment Partners first reported a position in TYRA in Q1 2024 and held it in 1 quarter. The position peaked at $2.51M in Q1 2024. 79 funds tracked by Wall St. Rank hold TYRA as of Q2 2024.

  • Nicholas Investment Partners reported no remaining Tyra Biosciences position as of Q2 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 152,968 Tyra Biosciences shares in Q2 2024, an estimated $2.51M.
  • Nicholas Investment Partners first reported a position in Tyra Biosciences in Q1 2024 and held it in 1 quarter.
  • Nicholas Investment Partners's Tyra Biosciences position peaked at $2.51M in Q1 2024.
  • 79 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2024.

Based on Nicholas Investment Partners's 13F filing for Q2 2024, filed 8 Aug 2024.